Cardiolink

What Cardiolink does

CardioLink is a privately held cardiac monitoring services company headquartered in Levittown, New York (Long Island), providing remote cardiac monitoring and patient support to physicians and patients in the Northeast US. The company operates a portfolio of eight core monitoring service lines: wireless telemetry via the Telesense Remote Cardiac Rhythm Monitor, arrhythmia event and memory loop monitoring, AFib and auto-trigger monitoring, Holter monitoring (24-hour to 7-day), pacemaker monitoring, ambulatory blood pressure (ABP) monitoring, and home INR testing. Its underlying technology stack uses cellular and Wi-Fi telemetry to automatically capture and transmit ECG recordings, physician-programmed rate thresholds to auto-trigger recordings, and HIPAA-compliant online portals for prescription submission and physician report access.

The company's go-to-market is prescription-driven: physicians send a prescription and CardioLink handles insurance verification, authorization, device delivery, patient training, 24/7/365 technician support, and final report generation. Revenue is generated primarily through insurance billing under contracts with over 75 insurance companies that have designated CardioLink as 'Provider of Choice', supplemented by direct patient billing arrangements for uninsured cases. Hardware revenue derives from supplying the monitoring devices themselves and consumables such as INR testing strips.

CardioLink is a small, privately held company with 1-10 employees and no disclosed funding history, M&A activity, or institutional ownership. Its operations are regionally concentrated, with a single facility in Levittown, NY serving as the main ABP hook-up site and the broader business serving the Northeast US market. No patents, awards, regulatory actions, or public financial disclosures were identified in the available data.

Name

Cardiolink

Legal name

CardioLink

Website

https://cardiolink.net

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

1–10 employees

Short description

CardioLink is a privately held, Long Island-based cardiac monitoring services company providing physicians and patients with remote monitoring across eight service lines including wireless telemetry, Holter, arrhythmia, AFib, pacemaker, ABP, and INR testing, billed primarily through 75+ contracted insurance providers.

Ownership category

akta.pro rank

Product category

Remote Cardiac Monitoring Services

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Home Health Care Services (8082)

akta.pro primary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

akta.pro secondary industry

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• Cardiac monitoring services
• Remote cardiac telemetry
• Arrhythmia monitoring
• Holter monitoring
• Pacemaker follow-up

Headquarters

HQ city

Levittown

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Cardiac Monitoring Services: CardioLink generates revenue through providing cardiac monitoring services billed to insurance companies and patients. The company is a contracted provider with many insurance companies and handles all insurance verification, authorizations, and billing directly. For uninsured patients, CardioLink arranges affordable payment solutions.
2. Device and Monitoring Equipment: Revenue from providing monitoring devices (wireless telemetry, Holter monitors, event monitors, ABP monitors, pacemaker monitors) and related consumables like INR testing strips, typically covered through insurance plans or direct patient billing.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Cardiolink provides physician-prescribed remote cardiac monitoring services, including transtelephonic arrhythmia, AFib auto-trigger, Holter, pacemaker, and ambulatory blood pressure monitoring, as well as a home INR monitoring program. It supplies patients with proprietary monitoring devices such as the Telesense wireless telemetry monitor and transmits readings via cellular/cloud infrastructure to technicians and prescribing physicians for clinical interpretation.

Product overview

CardioLink is a cardiac monitoring service provider offering a unified suite of monitoring services for physicians and patients. The core portfolio includes the Telesense Remote Cardiac Rhythm Monitor for wireless telemetry, Arrhythmia Monitoring with Event and Loop Monitors, AFib Monitoring/Auto Trigger Monitoring, Holter Monitoring (24-hour to 7-day), Pacemaker Monitoring, ABP Monitoring, and INR Home Monitoring Program. Supporting services include Online Prescriptions and Online Reports accessed via secure web portals. The company provides 24/7 technical support with highly trained technicians who assist patients with equipment setup and review transmitted data to generate reports for physicians.

Differentiator

Problem solved

Functional benefit

Products and services

• Telesense Remote Cardiac Rhythm Monitor Proprietary wireless telemetry cardiac rhythm monitor with cellular and cloud-based data transmission, supplied to patients enrolled in Cardiolink's remote cardiac monitoring programs and used by prescribing physicians to receive continuous ECG data.
• Arrhythmia Monitoring Service Transtelephonic monitoring service that captures and transmits patient cardiac rhythm data for technician review and physician interpretation, used by cardiologists and primary-care practices to detect intermittent arrhythmias outside the clinic.
• AFib Monitoring / Auto Trigger Monitoring Automated-trigger cardiac monitoring service focused on detecting atrial fibrillation episodes, designed for patients at risk of AFib and prescribed by their cardiologist or primary-care physician.
• Holter Monitoring Continuous ambulatory ECG Holter monitoring service that records patient heart rhythms over an extended period for later physician analysis, ordered for diagnostic workups by cardiology and primary-care practices.
• Pacemaker Monitoring Remote pacemaker follow-up monitoring service that transmits implanted-device data for clinical review and reporting back to the prescribing cardiology practice.
• Ambulatory Blood Pressure (ABP) Monitoring Outpatient ambulatory blood pressure monitoring service that captures longitudinal blood pressure readings for physician interpretation, used in hypertension workups ordered by cardiology and primary-care practices.
• INR Home Monitoring Program Home INR (anticoagulation) monitoring program that enables patients on warfarin and similar therapies to self-test and transmit coagulation results for clinical review and dosing guidance by their physician.

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature5 records

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Philips Healthcare: Philips, following its acquisition of BioTelemetry, offers a comprehensive cardiology portfolio including ECG, Holter, MCT, and imaging. It is a broad incumbent overlapping with CardioLink's full service suite, particularly Holter, event, and telemetry monitoring.
• Midmark (Mortara Instrument): Midmark, through its Mortara portfolio, manufactures and distributes resting ECG, Holter, and stress testing equipment used in cardiology offices. It is adjacent to CardioLink as a device and informatics provider rather than a direct service competitor.
• BioTelemetry (acquired by Philips): BioTelemetry, now part of Philips, is one of the largest ambulatory cardiac monitoring service providers in the US (MCOT, Holter, event). It competes with CardioLink across essentially the same service lines but at national scale with deeper R&D and payor relationships.

Direct peers

• ReactDx (React Health): ReactDx provides cardiac event monitoring, Holter, and MCT services with a physician-prescription-driven model very similar to CardioLink's. It competes directly in the regional and national ambulatory cardiac monitoring service market.
• Preventice Solutions (Boston Scientific): Preventice (now part of Boston Scientific) provides BodyGuardian remote cardiac monitoring services including MCT and Holter. It directly competes with CardioLink's wireless telemetry, arrhythmia, and Holter offerings with similar physician-prescription-driven service models.
• Ambulatory Monitoring, Inc. AMI manufactures MotionLoggers and other Holter/ABP monitors and supports clinical and research cardiac monitoring. It is directly comparable to CardioLink's Holter and ABP service lines.
• iRhythm Technologies: iRhythm's Zio suite provides patch-based, AI-driven ambulatory cardiac monitoring (Holter/event) with cloud-based reporting. It directly competes with CardioLink's Holter and arrhythmia event monitoring services, serving the same cardiologist prescribers with a more modern, app-connected workflow.
• Medicomp: Medicomp provides ambulatory cardiac monitoring services and devices (event monitors, Holter, telemetry) primarily in the Southeast US. It is a direct regional peer to CardioLink with a similar service-bureau business model.
• ScottCare Corporation: ScottCare manufactures and services Holter, event, and ambulatory blood pressure monitors, and provides monitoring service bureau capabilities. It is directly comparable to CardioLink as a competitor in ambulatory cardiac monitoring services.

Emerging players

• AliveCor: AliveCor provides AI-powered, smartphone-based ECG (KardiaMobile) for AFib and arrhythmia detection. While a different delivery model (direct-to-consumer/prescription), it increasingly competes for the same cardiology prescription volume and patient AFib monitoring use cases as CardioLink.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiolink